Lymphopenia in critically ill COVID-19 patients: A predictor factor of severity and mortality
Int J Lab Hematol
.
2021 Feb;43(1):e38-e40.
doi: 10.1111/ijlh.13351.
Epub 2020 Sep 30.
Authors
Amra Ziadi
1
,
Abdelhamid Hachimi
2
,
Brahim Admou
3
,
Raja Hazime
3
,
Imane Brahim
3
,
Fouzia Douirek
1
,
Youssef Zarrouki
1
,
Ahmed R El Adib
4
,
Said Younous
4
,
Abdenasser M Samkaoui
1
Affiliations
1
Polyvalent Intensive Care Unit, Arrazi Hospital, Mohammed VIth Teaching Center, Cadi Ayyad University, Marrakech, Morocco.
2
Medical Intensive Care Unit, Arrazi Hospital, Mohammed VIth Teaching Center, Cadi Ayyad University, Marrakech, Morocco.
3
Laboratory of Immunology, Center of Clinical Research, Mohammed VIth Teaching Center, Cadi Ayyad University, Marrakech, Morocco.
4
Polyvalent Intensive Care Unit, Child and mother Hospital, Mohammed VIth Teaching Center, Cadi Ayyad University, Marrakech, Morocco.
PMID:
32996680
PMCID:
PMC7537351
DOI:
10.1111/ijlh.13351
No abstract available
Keywords:
COVID-19; intensive care unit; lymphocyte; lymphocyte subset.
Publication types
Letter
Comment
MeSH terms
COVID-19*
Critical Illness
Humans
Intensive Care Units
Lymphopenia*
SARS-CoV-2